Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Charlestown.
Penn-Children's Hospital of Philadelphia Lifespan Brain Institute, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
JAMA Psychiatry. 2018 Sep 1;75(9):918-928. doi: 10.1001/jamapsychiatry.2018.1381.
Presently, 81 countries mandate the fortification of grain products with folic acid to lessen the risk of neural tube defects in the developing fetus. Epidemiologic data on severe mental illness suggest potentially broader effects of prenatal folate exposure on postnatal brain development, but this link remains unsubstantiated by biological evidence.
To evaluate associations among fetal folic acid exposure, cortical maturation, and psychiatric risk in youths.
DESIGN, SETTING, AND PARTICIPANTS: A retrospective, observational clinical cohort study was conducted at Massachusetts General Hospital (MGH) among 292 youths 8 to 18 years of age born between January 1993 and December 2001 (inclusive of folic acid fortification rollout ±3.5 years) with normative results of clinical magnetic resonance imaging, divided into 3 age-matched groups based on birthdate and related level of prenatal folic acid fortification exposure (none, partial, or full). Magnetic resonance imaging was performed between January 2005 and March 2015. Two independent, observational, community-based cohorts (Philadelphia Neurodevelopmental Cohort [PNC] and National Institutes of Health Magnetic Resonance Imaging Study of Normal Brain Development [NIH]) comprising 1078 youths 8 to 18 years of age born throughout (PNC, 1992-2003) or before (NIH, 1983-1995) the rollout of folic acid fortification were studied for replication, clinical extension, and specificity. Statistical analysis was conducted from 2015 to 2018.
United States-mandated grain product fortification with folic acid, introduced in late 1996 and fully in effect by mid-1997.
Differences in cortical thickness among nonexposed, partially exposed, and fully exposed youths (MGH) and underlying associations between age and cortical thickness (all cohorts). Analysis of the PNC cohort also examined the association of age-cortical thickness slopes with the odds of psychotic symptoms.
The MGH cohort (139 girls and 153 boys; mean [SD] age, 13.3 [2.3] years) demonstrated exposure-associated cortical thickness increases in bilateral frontal and temporal regions (9.9% to 11.6%; corrected P < .001 to P = .03) and emergence of quadratic (delayed) age-associated thinning in temporal and parietal regions (β = -11.1 to -13.9; corrected P = .002). The contemporaneous PNC cohort (417 girls and 444 boys; mean [SD] age, 13.5 [2.7] years) also exhibited exposure-associated delays of cortical thinning (β = -1.59 to -1.73; corrected P < .001 to P = .02), located in similar regions and with similar durations of delay as in the MGH cohort. Flatter thinning profiles in frontal, temporal, and parietal regions were associated with lower odds of psychosis spectrum symptoms in the PNC cohort (odds ratio, 0.37-0.59; corrected P < .05). All identified regions displayed earlier thinning in the nonexposed NIH cohort (118 girls and 99 boys; mean [SD] age, 13.3 [2.6] years).
The results of this study suggest an association between gestational exposure to fortification of grain products with folic acid and altered cortical development and, in turn, with reduction in the risk of psychosis in youths.
目前,有 81 个国家强制要求在谷物产品中添加叶酸,以降低胎儿神经管缺陷的风险。流行病学数据表明,严重精神疾病可能会对产前叶酸暴露对产后大脑发育产生更广泛的影响,但生物学证据尚未证实这一联系。
评估胎儿叶酸暴露、皮质成熟度和青少年精神疾病风险之间的关联。
设计、地点和参与者:在马萨诸塞州综合医院(MGH)进行了一项回顾性、观察性临床队列研究,共有 292 名 8 至 18 岁的青少年参与,出生于 1993 年 1 月至 2001 年 12 月(包括叶酸强化剂的推出时间±3.5 年),他们的临床磁共振成像结果均为正常,并根据出生日期和相关的产前叶酸强化剂暴露水平(无、部分或完全)分为 3 个年龄匹配组。磁共振成像于 2005 年 1 月至 2015 年 3 月进行。两个独立的、观察性的、基于社区的队列(费城神经发育队列[PNC]和美国国立卫生研究院正常脑发育磁共振成像研究[NIH])共包括 1078 名 8 至 18 岁的青少年,他们出生于叶酸强化剂推出(PNC,1992-2003 年)或推出之前(NIH,1983-1995 年),用于复制、临床扩展和特异性研究。统计分析于 2015 年至 2018 年进行。
美国强制要求谷物产品添加叶酸,于 1996 年末推出,并于 1997 年年中全面生效。
MGH 队列(139 名女孩和 153 名男孩;平均[SD]年龄,13.3[2.3]岁)中双侧额叶和颞叶区域的皮质厚度(9.9%至 11.6%;校正 P<0.001 至 P=0.03)以及颞叶和顶叶区域出现的与年龄相关的二次(延迟)变薄(β=-11.1 至-13.9;校正 P=0.002)与暴露有关。同期的 PNC 队列(417 名女孩和 444 名男孩;平均[SD]年龄,13.5[2.7]岁)也表现出与暴露相关的皮质变薄延迟(β=-1.59 至-1.73;校正 P<0.001 至 P=0.02),位于与 MGH 队列相似的区域,延迟时间也相似。在额叶、颞叶和顶叶区域更平坦的变薄模式与 PNC 队列中较低的精神病谱系症状的可能性相关(优势比,0.37 至 0.59;校正 P<0.05)。在未暴露于 NIH 队列(118 名女孩和 99 名男孩;平均[SD]年龄,13.3[2.6]岁)中,所有确定的区域都显示出更早的变薄。
这项研究的结果表明,胎儿在妊娠期间暴露于谷物产品强化的叶酸与皮质发育的改变有关,进而与青少年精神疾病风险的降低有关。